Evidence map›Paper›PMID 27383183›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2016

Altered TGF-α/β signaling drives cooperation between breast cancer cell populations.

Omar E Franco, Darren R Tyson, Katherine C Konvinse, Akshata R Udyavar, Lourdes Estrada, Vito Quaranta, Susan E Crawford, Simon W Hayward

Open access · greenAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. MicroRNA-mediated autophagy regulation in thyroid cancer drug resistance.Cancer drug resistance (Alhambra, Calif.) · 2025
    Review
  3. Microfluidic-based human prostate-cancer-on-chip.Frontiers in bioengineering and biotechnology · 2024
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Omar E FrancoDepartment of Surgery, NorthShore University HealthSystem, Evanston, Illinois, USA.
Darren R TysonDepartment of Cancer Biology, Vanderbilt University Medical Center, Vanderbilt University, Nashville, Tennessee, USA.
Katherine C KonvinseDepartment of Urologic Surgery, Vanderbilt University Medical Center, Vanderbilt University, Nashville, Tennessee, USA; and.
Akshata R UdyavarDepartment of Cancer Biology, Vanderbilt University Medical Center, Vanderbilt University, Nashville, Tennessee, USA.
Lourdes EstradaDepartment of Cancer Biology, Vanderbilt University Medical Center, Vanderbilt University, Nashville, Tennessee, USA.
Vito QuarantaDepartment of Cancer Biology, Vanderbilt University Medical Center, Vanderbilt University, Nashville, Tennessee, USA.
Susan E CrawfordDepartment of Surgery, NorthShore University HealthSystem, Evanston, Illinois, USA.
Simon W HaywardDepartment of Surgery, NorthShore University HealthSystem, Evanston, Illinois, USA; Department of Urologic Surgery, Vanderbilt University Medical Center, Vanderbilt University, Nashville, Tennessee, USA; and Department of Cancer Biology, Vanderbilt University Medical Center, Vanderbilt University, Nashville, Tennessee, USA shayward@northshore.org.
Vanderbilt University Medical Center · USNorthShore University HealthSystem · USVanderbilt University · US

Funding

TrainingU54CA113007 · NCI · VANDERBILT UNIVERSITY · PI QUARANTA, VITO · 2004 to 2014
$19.2M
Predicting Prostate Cancer AggressivenessU01CA151924 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI ANDERSON, ALEXANDER ROBERTSON ALLAN, AYALA, GUSTAVO ENRIQUE · 2011 to 2015
$2.8M
NCI NIH HHS U01 CA151924NCI NIH HHS U54 CA113007
6 · The paper itself

Abstract

The role of tumor heterogeneity in regulating disease progression is poorly understood. We hypothesized that interactions between subpopulations of cancer cells can affect the progression of tumors selecting for a more aggressive phenotype. We developed an in vivo assay based on the immortalized nontumorigenic breast cell line MCF10A and its Ras-transformed derivatives AT1 (mildly tumorigenic) and CA1d (highly tumorigenic). CA1d cells outcompeted MCF10A, forming invasive tumors. AT1 grafts were approximately 1% the size of CA1d tumors when initiated using identical cell numbers. In contrast, CA1d/AT1 mixed tumors were larger than tumors composed of AT1 alone (100-fold) or CA1d (3-fold), suggesting cooperation in tumor growth. One of the mechanisms whereby CA1d and AT1 were found to cooperate was by modulation of TGF-α and TGF-β signaling. Both of these molecules were sufficient to induce changes in AT1 proliferative potential in vitro. Reisolation of AT1 tumor-derived (AT1

Indexed as

Signal TransductionAnimalsBreast NeoplasmsCell Line, TumorCell MovementCell Transformation, NeoplasticEpitheliumHumansMice, SCIDTransforming Growth Factor alphaTransforming Growth Factor betaTransforming Growth Factor alphaTransforming Growth Factor betaepithelial paracrine interactionsintratumor cooperationtumor heterogeneity

Identifiers

PMID27383183
PMCPMC5024699
OpenAlexW2470602894

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.